Antibodies |
|
Sars-CoV-2 Nucleocapsid |
GeneTex |
GTX135357;RRID: AB_2868464
|
HNF4a |
Life Technologies |
MA1-199;RRID: AB_2633309
|
dsRNA |
SCICONS English & Scientific Consulting |
J2;RRID: AB_2651015
|
KRT17 |
Abcam |
ab53707;RRID: AB_869865
|
|
Bacterial and virus strains |
|
SARS-CoV-2 (USA_WA1/2020) |
BEI |
NR-52281 |
|
Chemicals, peptides, and recombinant proteins |
|
Tocilizumab |
Selleck |
A2012 |
|
Critical commercial assays |
|
RNeasy Micro Kit |
Qiagen |
74004 |
Chromium Next GEM Automated Single Cell 3′ Library and Gel Bead Kit v3.1 |
10X Genomics |
1000147 |
Custom Luminex Assay |
R&D Systems |
NA |
|
Deposited data |
|
Raw and analyzed sequencing data |
This study |
GEO: GSE210061
|
|
Experimental models: Cell lines |
|
Vero E6 |
ATCC |
CRL-1586 |
H1 (WA01) hPSCs |
WiCell |
NA |
Allen hPSCS |
the Allen Institute |
NA |
1016 (DiPS 1016 SevA) hPSCs |
Harvard Stem Cell Institute iPS Core |
NA |
|
Oligonucleotides |
|
Primers for RPLP0, SARS-CoV-2, Albumin, HNF4a, IL-6, MCP-1 See Table S3
|
N/A |
N/A |
|
Software and algorithms |
|
Code used to create Figures 2A and S3
|
This study |
Code to create Figures 2A and S3.zip |